TXG (TXG) Stock Price & Analysis
TXG (TXG) fell 0.90% to USD 62.65 as of September 8, 2026 at 10:17 UTC, according to Nexqual real-time market data.
TXG last closed at USD 62.65; the session ranged USD 60.99–63.48 on volume of 1,469,824 shares. Market capitalization is —, with a 52-week range of USD 11.16–66.94 (NMS). Source: Nexqual, September 8, 2026 at 10:17 UTC.
Key Statistics (as of September 8, 2026 at 10:17 UTC)
| Price | USD 62.65 |
|---|---|
| Change | ▼ 0.90% (down) |
| Previous Close | USD 62.65 |
| Open | USD 62.65 |
| Day Range | USD 60.99 – 63.48 |
| 52-Week Range | USD 11.16 – 66.94 |
| Volume | 1,469,824 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TXG)
Nexqual's technical model rates TXG "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 10:17 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.56 (neutral) |
| vs SMA50 | Above (USD 50.87) |
| MACD | 3.61 (positive) |
From TXG's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TWST | Twist Bioscience Corporation | USD 124.72 | ▼ 4.79% |
| BEAM | Beam Therapeutics Inc. | USD 29.66 | ▲ 1.26% |
| PACB | Pacific Biosciences of Californ | USD 1.35 | ▲ 2.27% |
| VCYT | Veracyte, Inc. | USD 42.53 | ▼ 5.24% |
| GH | Guardant Health, Inc. | USD 161.41 | ▼ 1.01% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:17 UTC. This page is informational and not investment advice.